Experts React to Approval of Pfizer’s CIBINQO for Teens with Refractory AD

Press/Media

Period	12 Feb 2023

Media coverage

Title	Experts React to Approval of Pfizer’s CIBINQO for Teens with Refractory AD
Media name/outlet	Practical Dermatology
Country/Territory	United States
Date	12/02/23
URL	https://practicaldermatology.com/news/fda-oks-pfizers-cibinqo-for-teens-with-refractory-ad?c4src=topic:eczema:feed
Persons	Peter Lio